Year To Quarter End Consolidated Statement Of Comprehensive Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7549480

Concept 2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-295,756,000 JPY
-548,696,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.